Factor VIII Dosing

Calculates the required IU dose to raise factor VIII levels to a target percent based on weight and desired activity.

kglbs
%
%

Indications for Use

Used for bleeding treatment and prophylaxis in hemophilia A, including on‑demand control of acute bleeds, perioperative coverage, and routine prophylaxis to prevent joint disease. Prophylaxis with FVIII (standard or extended‑half‑life) markedly reduces annualized bleed rates (NEJM efanesoctocog alfa trial, adults/children) 1 [Level I evidence] and is the cornerstone of disease‑modifying therapy. Clinical utility: restores hemostasis by targeting desired FVIII levels based on bleed severity or surgical risk.

Insights & Cautions

Dose by weight to reach a target FVIII rise (≈2 IU/kg per 1% increase), rounding to the nearest vial; give smaller, more frequent doses in active bleeding or perioperative settings to avoid troughs.

  • Verify baseline FVIII level and inhibitor status before dosing.
  • Avoid overdosing in elderly or renal‑impaired patients due to thrombosis risk.
  • Recheck levels after large or surgical doses to confirm target recovery.